SBC Medical Group (NASDAQ:SBC) CEO Yoshiyuki Aikawa Sells 4,422,900 Shares

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) CEO Yoshiyuki Aikawa sold 4,422,900 shares of the company’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $2.12, for a total value of $9,376,548.00. Following the completion of the sale, the chief executive officer directly owned 861,600 shares of the company’s stock, valued at approximately $1,826,592. This trade represents a 83.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

SBC Medical Group Trading Down 2.8%

NASDAQ:SBC traded down $0.11 during mid-day trading on Tuesday, reaching $3.75. The company’s stock had a trading volume of 21,442 shares, compared to its average volume of 25,271. The company’s fifty day simple moving average is $4.32 and its two-hundred day simple moving average is $4.09. The stock has a market cap of $384.68 million, a P/E ratio of 9.15 and a beta of 1.19. SBC Medical Group Holdings Incorporated has a twelve month low of $2.91 and a twelve month high of $5.75. The company has a debt-to-equity ratio of 0.07, a current ratio of 5.10 and a quick ratio of 5.06.

Analysts Set New Price Targets

SBC has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of SBC Medical Group in a report on Monday, December 29th. BTIG Research initiated coverage on shares of SBC Medical Group in a research note on Friday. They issued a “buy” rating and a $8.00 target price for the company. Two investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, SBC Medical Group has a consensus rating of “Hold” and a consensus price target of $8.50.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SBC. Geode Capital Management LLC lifted its stake in shares of SBC Medical Group by 37.6% during the 4th quarter. Geode Capital Management LLC now owns 262,043 shares of the company’s stock valued at $1,129,000 after buying an additional 71,664 shares in the last quarter. SBI Securities Co. Ltd. raised its stake in SBC Medical Group by 227.3% in the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock worth $251,000 after buying an additional 37,623 shares in the last quarter. Millennium Management LLC bought a new position in shares of SBC Medical Group during the third quarter valued at approximately $219,000. Charles Schwab Investment Management Inc. raised its holdings in SBC Medical Group by 91.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 27,341 shares of the company’s stock worth $118,000 after buying an additional 13,074 shares during the last quarter. Finally, New York State Common Retirement Fund purchased a new stake in shares of SBC Medical Group during the 2nd quarter valued at about $104,000. 60.82% of the stock is owned by institutional investors.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.